Systemic Bevacizumab for Severe Recurrent Respiratory Papillomatosis

Recurrent respiratory papillomatosis (RRP) is the most common benign pediatric laryngeal neoplasm. Various adjuvant medical therapies have failed to reliably decrease surgical frequency in this challenging airway disease. Recently, systemic bevacizumab has shown promise in advanced, treatment-resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatineni, Swetha, Warren, Zachary, Applebaum, Mark A., Baroody, Fuad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726241/
https://www.ncbi.nlm.nih.gov/pubmed/36483909
http://dx.doi.org/10.1155/2022/2767996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726241/
https://www.ncbi.nlm.nih.gov/pubmed/36483909
http://dx.doi.org/10.1155/2022/2767996

Ejemplares similares